UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma
Author:
Publisher
China Science Publishing & Media Ltd.
Link
https://engine.scichina.com/doi/pdf/43153DFBA3474C619C68D2858C45AF5A
Reference48 articles.
1. Walker EV, Davis FG, Affiliates CF. Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013. Neuro-oncology 2019, 3.
2. Lan P, Li M, Wang Y, Wang J, Li L, Zhang S, Zhang X. Y-box protein-1 modulates circSPECC1 to promote glioma tumorigenesis via miR-615-5p/HIP1/AKT axis. Acta Biochim Biophys Sin, 2023, 55: 1902-1912.
3. Nitta M, Muragaki Y, Maruyama T, Iseki H, Ikuta S, Konishi Y, Saito T. Updated Therapeutic Strategy for Adult Low-Grade Glioma Stratified by Resection and Tumor Subtype. Neurol Med Chir(Tokyo), 2013, 53: 447-454.
4. Bradshaw TD, Stevens MFG, Zhang J. Temozolomide: Mechanisms of Action, Repair and Resistance. Current Molecular Pharmacology 2012, 5: -.
5. Hershko A, Ciechanover A. THE UBIQUITIN SYSTEM. Annu Rev Biochem, 1998, 67: 425-479.
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Forms of Non-Apoptotic Cell Death and Their Role in Gliomas—Presentation of the Current State of Knowledge;Biomedicines;2024-07-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3